Microbial biosynthesis of opioid antagonists: a novel, low-cost method for producing addiction pharmacotherapies
Ended Project Grant Awarded Last action
- Award ID
- R43DA044069
- Recipient
-
Antheia, Inc. UEI VKG2HCDNHAK3
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $240,000
Award facts
- Assistance listing
- 93.279 Drug Use and Addiction Research Programs
- Completion date
- Originally
- Funding
-
- $235,000.00 Federal
- $5,000.00 Non-federal
- Place of performance
- Menlo Park, CA 94025, USA
Award details come from USAspending.gov.
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | $5,000 | $0 | |
| Amendment | $5,000 | $5,000 | |
| Amendment | $0 | $0 | |
| Original award | $225,000 | $0 |
Quick answers
Who received award R43DA044069?
R43DA044069 was awarded to Antheia, Inc. by National Institute on Drug Abuse (National Institutes of Health) on April 1, 2017.
How much is award R43DA044069 worth?
$240,000 has been obligated on R43DA044069: $235,000 in federal funding and $5,000 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award